跳至主要内容
临床试验/ACTRN12616001717448
ACTRN12616001717448已完成未知

Reliability and validity of biofeedback insoles for people with diabetes and peripheral neuropathy

Wound Management Innovation CRC0 个研究点目标入组 15 人开始时间: 2016年12月14日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
15

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • Diabetes mellitus type 1 or 2
  • - Aged 18 years or older
  • - Peripheral Neuropathy (as determined using a 10-gram Semmes Weinstein monofilament, in line with criteria from the International Working Group on the Diabetic Foot (IWGDF; Schaper et al, 2016)
  • - Ability and willingness to cooperate with the study requirements

排除标准

  • - Peripheral artery disease, determined by a toe pressure <30mmHg (Hinchliffe et al, 2016)
  • - Diabetic foot ulcer
  • - Charcot neuroarthropathy
  • - Major amputation (i.e. above the ankle)
  • - Not able to walk for 30m. without external support (e.g. crutches)

研究者

发起方
Wound Management Innovation CRC

相似试验